¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inactive mutant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactive charcoal
    ºÒȰ¼º½¡
  • inactive marrow
    ºñȰ¼º°ñ¼ö
  • inactive serum
    ºñȰ¼ºÇ÷û
  • auxotrophic mutant
    ¿µ¾ç¿ä±¸µ¹¿¬º¯ÀÌÁÖ
  • biochemical mutant
    »ýÈ­ÇÐÀûµ¹¿¬º¯ÀÌÁÖ
  • cold adapted mutant
    Àú¿ÂÀûÀÀµ¹¿¬º¯ÀÌÁÖ
  • conditional lethal mutant
    Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌÁÖ
  • deletion mutant
    °á¼Õµ¹¿¬º¯ÀÌÁÖ
  • host-range mutant
    ¼÷ÁÖ¹üÀ§µ¹¿¬º¯ÀÌÁÖ
  • morphological mutant
    Çüŵ¹¿¬º¯ÀÌÁÖ
  • mutant
    1. µ¹¿¬º¯ÀÌ- 2. µ¹¿¬º¯ÀÌÁÖ, µ¹¿¬º¯ÀÌü
  • mutant frequency
    µ¹¿¬º¯ÀÌÁÖºóµµ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • temperature-sensitive mutant
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌÁÖ
  • virulent mutant
    µ¶¼ºµ¹¿¬º¯ÀÌÁÖ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mutant
    µ¹¿¬º¯ÀÌ-, µ¹¿¬º¯ÀÌÁÖ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactive charcoal
    ºÒȰ¼º½¡
  • inactive marrow
    ºñȰ¼º°ñ¼ö
  • inactive serum
    ºñȰ¼ºÇ÷û
  • auxotrophic mutant
    ¿µ¾ç¿ä±¸µ¹¿¬º¯ÀÌÁÖ
  • biochemical mutant
    »ýÈ­ÇÐÀûµ¹¿¬º¯ÀÌü, »ýÈ­ÇÐÀûº¯ÀÌÁ¾
  • cold adapted mutant
    Àú¿ÂÀûÀÀµ¹¿¬º¯ÀÌü
  • conditional lethal mutant
    Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌÁÖ
  • deletion mutant
    °á¼ÕÇüµ¹¿¬º¯ÀÌÁÖ
  • mutant frequency
    µ¹¿¬º¯ÀÌüºóµµ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • host-range mutant
    ¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ, ¼÷ÁÖ¿ªµ¹¿¬º¯ÀÌü
  • mutant
    µ¹¿¬º¯ÀÌ-, µ¹¿¬º¯ÀÌÁÖ
  • morphological mutant
    Çüź¯À̱Õ
  • mutant species
    µ¹¿¬º¯ÀÌÁ¾
  • nutritional mutant
    ¿µ¾çº¯ÀÌÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactive charcoal
    ºÒȰ¼ºÅº(ÝÕüÀàõ÷©).
  • inactive marrow
    Ȳ°ñ¼ö(üÜÍéâÐ).
  • inactive marrow
    Ȳ°ñ¼ö(Ì·Ë­Ëà).
  • inactive phase
    ºñȰµ¿±â
  • inactive precursor
    ºñȰ¼º Àü±¸¹°Áú.
  • inactive serum
    ºñȰ¼ºÇ÷û.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactive charcoal
    ºÒȰ¼ºÅº(ÝÕüÀàõ÷©).
  • inactive marrow
    Ȳ°ñ¼ö(Ì·Ë­Ëà).
  • inactive marrow
    Ȳ°ñ¼ö(üÜÍéâÐ).
  • inactive phase
    ºñȰµ¿±â
  • inactive precursor
    ºñȰ¼º Àü±¸¹°Áú.
  • inactive serum
    ºñȰ¼ºÇ÷û.
  • x-inactive-specific transcript,gene(xist)
    X-ºÒȰ¼º-ƯÀÌÀü»ç
  • auxotrophic mutant
    ¿µ¾ç¿ä±¸¼º µ¹¿¬º¯ÀÌÁÖ
  • biochemical mutant
    »ýÈ­ÇÐÀû µ¹¿¬º¯ÀÌü(¡­ÔÍæÔܨì¶ô÷).
  • biochemical mutant
    »ýÈ­ÇÐÀû º¯ÀÌÁ¾(¡­Ü¨ì¶ðþ).
  • cold adapted mutant
    ÇÑ·©ÀûÀÀ µ¹¿¬º¯ÀÌü
  • conditional lethal mutant
    Á¶°ÇÄ¡»ç µ¹¿¬º¯ÀÌÁÖ
  • deletion mutant
    °á¼ÕÇüµ¹¿¬º¯ÀÌÁÖ
  • host-range mutant
    ¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ
  • leaky mutant
    ´©Ãâµ¹¿¬º¯À̱Õ(¡­ÔÍæ× Ü¨ì¶Ð¶).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] [µ¹¿¬]º¯ÀÌÀ¯ÀüÀÚ
  • Inactive phase
    ºñȰµ¿±â
    [¿¾ ¿ë¾î] ÈÞÁö±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asporogenic mutant
    ¹«(Ùí)Ȧ¾¾ º¯ÀÌÁ¾ (ܨì¶ðú)
  • asporogenous mutant
    Ȧ¾¾ºÒÇü¼º º¯ÀÌÁ¾ (ÝÕû¡à÷ ܨì¶ðú)
  • biochemically deficient mutant
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) °áÇ̺¯ÀÌÁ¾(ÌÀù¹Ü¨ì¶ðú)
  • biochemical mutant
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) º¯ÀÌÁ¾(ܨì¶ðú)
  • cofactor-requiring mutant
    º¸(Á¶)ÀÎÀڿ䱸 º¯ÀÌü(ÜÍ(ð¾)ì×í­é©Ï´Ü¨ì¶ô÷)
  • cold-sensitive mutant
    ³Ã¹Î°¨ º¯ÀÌü(Ò²ÚÂÊïܨì¶ô÷)
  • conditional lethal mutant
    Á¶°ÇºÎ Ä¡»çº¯ÀÌü(ðÉËìݾöÈÞÝܨì¶ô÷)
  • conditional mutant
    Á¶°ÇºÎ º¯ÀÌü(ðÉËìݾܨì¶ô÷)
  • cryptic mutant
    ÀáÀç º¯ÀÌü(íÖî¤Ü¨ì¶ô÷)
  • deficiency mutant
    "°áÇÌ º¯ÀÌü(ÌÀù¹Ü¨ì¶ô÷), (ÔÒ) auxotroph"
  • DNA-arrest mutant
    DNAÁ¤Áö(ïÎò­) º¯ÀÌü(ܨì¶ô÷)
  • DNA-delay mutant
    DNAÁöü º¯ÀÌü(òÀôòܨì¶ô÷)
  • DNA-negative mutant
    ¹«(Ùí)DNA º¯ÀÌü(ܨì¶ô÷)
  • dual-effect mutant
    ÀÌÁßÈ¿°ú º¯ÀÌü(ì£ñìüùÍýܨì¶ô÷)
  • host-range mutant
    ¼÷ÁÖ¹üÀ§ º¯ÀÌÁÖ(âÖñ«ÛôêÌܨì¶ñ»)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactive
    ºÒȰ¼ºÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Xi inactive X Chromosome
CAC/CIC chronic active/inactive cirrhosis
HGMCR human genetic mutant cell repository
hr hairless [mouse]; host-range [mutant]; hour
IRA immunoradioassay; immunoregulatory alpha-globulin; inactive renin activity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IR inactive renin
m Mutant
mt Mutant
MASA Mutant allele specific amplification
MFs Mutant frequencies
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • inactive
    ºÒȰ¼ºÀÇ, ºñȰ¼º
    Ȱµ¿¼ºÀÌ ¾ø´Â.
  • leaky mutant
    ´©Ãâ µ¹¿¬º¯ÀÌ ±Õ
  • mutant frequency
    º¯ÀÌü ºóµµ, µ¹¿¬º¯ÀÌü ºóµµ
  • mutant species
    µ¹¿¬º¯ÀÌÁ¾
  • nutritional mutant
    ¿µ¾ç º¯ÀÌÁÖ
  • virulent mutant
    µ¶¼º º¯ÀÌ ÁÖ, µ¶¼º º¯ÀÌ ±ÕÁÖ, µ¶¼º µ¹¿¬º¯ÀÌ ÁÖ, µ¶¼º µ¹¿¬º¯ÀÌ ±ÕÁÖ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
inactive mutant A mutant that is not phenotypically manifest.
Synonym: silent mutant.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
inactive Not active.
(18 Nov 1997)
inactive repressor A repressor that cannot combine with an operator gene until it has combined with a corepressor (usually a product of a protein pathway); after activation, the repressor arrests production of the proteins controlled by the operator gene; a homeostatic mechanism for regulation of repressible enzyme systems.
Synonym: aporepressor.
(05 Mar 2000)
inactive tuberculosis A scar or a calcified, fibrous, or caseous nodule in the lung pleura, lymph node, or other organ, resulting from previous tuberculosis that has regressed; reactivation is possible.
Synonym: arrested tuberculosis, inactive tuberculosis.
(05 Mar 2000)
active mutant A mutant with overt phenotypic expression.
(05 Mar 2000)
amber mutant A mutant with a mutation resulting in a UAG codon.
(05 Mar 2000)
auxotrophic mutant Mutant with a nutritional requirement not present in the wild type organism.
Synonym: defective organism, deficiency mutant.
(05 Mar 2000)
gap mutant <molecular biology> A fruit fly of the genus Drosophila which is missing a number of adjacent segments because the segments failed to develop.
(09 Oct 1997)
rats, mutant strains Rats bearing mutant genes which are phenotypically expressed in the animals.
(12 Dec 1998)
virulent phage mutant A mutant of a phage that is unable to establish lysogeny.
(05 Mar 2000)
relaxed mutant A mutant bacterium that continues to synthesise RNA in a medium that lackscertain nutrients or amino acids which that sort of bacterium normallyneeds present before it can make RNA.
(09 Oct 1997)
ced mutant <organism> Giant multinucleate fresh water amoeba (up to 5mm long) much used for studies on the mechanism of cell locomotion.
(18 Nov 1997)
cell division cycle mutant A yeast cell which has cell division cycle genes that have mutated to become sensitive to temperature, at certain temperatures (usually high ones), various parts of the normal yeast cell cycle become abnormal, and in some strains the yeast cell does not survive at all.
(09 Oct 1997)
petite mutant <molecular biology, organism> A class of yeast mutants, most studied in Saccharomyces cerevisiae. Mutants grow slowly and rely on anaerobic respiration: mitochondria, although present, have reduced cristae and are functionally defective (termed promitochondria). There are three types of petite mutant:
(i) Segregational mutants that show Mendelian behaviour and result from mutations in mitochondrial genes located in the nucleus.
(ii) Neutral petites, which are recessive genotypes and result from the complete absence of mitochondrial DNA.
(iii) Suppressive petites, in which most of the mitchondrial DNA is lost (60-99%), though what remains is often amplified.
(06 Oct 1997)
mice, mutant strains Mice bearing mutant genes which are phenotypically expressed in the animals.
(12 Dec 1998)
minute mutant <genetics, molecular biology> A class of recessive lethal mutants of Drosophila The heterozygotes grow more slowly, are smaller and less fertile than the wild type flies. There are about 40 loci that produce minute mutants.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mutant
    º¯Á¾;µ¹¿¬ º¯ÀÌü
  • inactive
    ÇѰ¡ÇÑ
  • inactive
    Ȱµ¿ÇÏÁö ¾ÊÀº;¿òÁ÷ÀÌÁö ¾Ê´Â;°ÔÀ¸¸¥;(±â°èµîÀÌ)¿òÁ÷ÀÌÁö ¾Ê´Â;»ç¿ëµÇÁö ¾Ê°í ÀÖ´Â(È­,¹°)ºÒȰ¼ºÀÇ;(±¤)ºÒ¼±±¤¼ºÀÇ(¹°)¹æ»ç´ÉÀÌ ¾ø´Â;(±º)Çö¿ªÀÌ ¾Æ´Ñ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á